A viral nanoparticle with dual function as an anthrax antitoxin and vaccine.
The recent use of Bacillus anthracis as a bioweapon has stimulated the search for novel antitoxins and vaccines that act rapidly and with minimal adverse effects. B. anthracis produces an AB-type toxin composed of the receptor-binding moiety protective antigen (PA) and the enzymatic moieties edema f...
Main Authors: | Darly J Manayani, Diane Thomas, Kelly A Dryden, Vijay Reddy, Marc E Siladi, John M Marlett, G Jonah A Rainey, Michael E Pique, Heather M Scobie, Mark Yeager, John A T Young, Marianne Manchester, Anette Schneemann |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-10-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC2000967?pdf=render |
Similar Items
-
Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
by: Heather M Scobie, et al.
Published: (2006-10-01) -
Correction: Anthrax Toxin Receptor 2–Dependent Lethal Toxin Killing In Vivo.
by: Heather M Scobie, et al.
Published: (2008-10-01) -
Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formation.
by: Heather M Scobie, et al.
Published: (2007-03-01) -
Divalent metal ion coordination by residue T118 of anthrax toxin receptor 2 is not essential for protective antigen binding.
by: Heather M Scobie, et al.
Published: (2006-12-01) -
Delayed toxicity associated with soluble anthrax toxin receptor decoy-Ig fusion protein treatment.
by: Diane Thomas, et al.
Published: (2012-01-01)